Cases & Deals

  • Home
  • Practices
  • Board of Trustees of Univ. of Illinois files patent infringement action against Aurobindo involving generic versions of Prezista®

Share

Board of Trustees of Univ. of Illinois files patent infringement action against Aurobindo involving generic versions of Prezista®

2018

Client(s) Board of Trustees of the University of Illinois

Jones Day is representing the Board of Trustees of the University of Illinois in a patent infringement action against Aurobindo Pharma USA, Inc. relating to the defendant’s submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of Prezista® (darunavir), a market-leading protease inhibitor. The Firm is working closely with the United States, which co-owns the patent-in-suit, and with our licensee Janssen Products, L.P., which markets Prezista® (darunavir).

US Department of Health and Human Services et al. v. Aurobindo Pharma USA Inc., No. 3-17-cv-06911 (D.N.J.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.